PortfoliosLab logoPortfoliosLab logo
INMD vs. GMED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INMD vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in InMode Ltd. (INMD) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INMD achieves a 3.06% return, which is significantly higher than GMED's -9.76% return.


INMD

1D
0.30%
1M
2.30%
6M
-3.63%
YTD
3.06%
1Y
10.19%
3Y*
-29.84%
5Y*
-23.25%
10Y*
ALL TIME*
12.12%

GMED

1D
-1.83%
1M
-1.66%
6M
-13.11%
YTD
-9.76%
1Y
49.68%
3Y*
10.13%
5Y*
-1.08%
10Y*
12.86%
ALL TIME*
13.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$96.46M$126.87M$149.45M
$8.32M$9.69M$11.98M

INMD vs. GMED - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
INMD
InMode Ltd.
3.06%-12.04%-24.91%-37.70%-49.42%197.30%21.12%187.71%
GMED
Globus Medical, Inc.
-9.76%5.56%55.21%-28.25%2.87%10.70%10.77%21.10%

Correlation

The correlation between INMD and GMED is 0.37, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.37

Correlation (3Y)
Balances recent behavior with more history.

0.32

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.40

Correlation (All Time)
Calculated using the full available price history since Aug 8, 2019

0.35

Fundamentals

Market Cap

INMD:

$870.26M

GMED:

$10.63B

EPS

INMD:

$1.36

GMED:

$4.28

PE Ratio

INMD:

11.11

GMED:

18.39

PS Ratio

INMD:

2.58

GMED:

3.48

PB Ratio

INMD:

1.46

GMED:

2.30

Total Revenue (TTM)

INMD:

$374.64M

GMED:

$3.10B

Gross Profit (TTM)

INMD:

$291.61M

GMED:

$1.58B

EBITDA (TTM)

INMD:

$98.61M

GMED:

$803.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INMD vs. GMED — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

INMD
INMD Risk / Return Rank: 5555
Overall Rank
INMD Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
INMD Sortino Ratio Rank: 5353
Sortino Ratio Rank
INMD Omega Ratio Rank: 5252
Omega Ratio Rank
INMD Calmar Ratio Rank: 5757
Calmar Ratio Rank
INMD Martin Ratio Rank: 5656
Martin Ratio Rank

GMED
GMED Risk / Return Rank: 8080
Overall Rank
GMED Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
GMED Sortino Ratio Rank: 8383
Sortino Ratio Rank
GMED Omega Ratio Rank: 8080
Omega Ratio Rank
GMED Calmar Ratio Rank: 8282
Calmar Ratio Rank
GMED Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

INMD vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for InMode Ltd. (INMD) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INMDGMEDDifference
Sharpe ratioReturn per unit of total volatility

-0.68

Sortino ratioReturn per unit of downside risk

-1.49

Omega ratioGain probability vs. loss probability

1.09

1.26

-0.17

Calmar ratioReturn relative to maximum drawdown

0.47

2.26

-1.79

Martin ratioReturn relative to average drawdown

0.91

4.92

-4.01

INMD vs. GMED - Sharpe Ratio Comparison

The current INMD Sharpe Ratio is 0.33, which is lower than the GMED Sharpe Ratio of 1.01. The chart below compares the historical Sharpe Ratios of INMD and GMED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INMD vs. GMED - Drawdown Comparison

The maximum INMD drawdown since its inception was -86.96%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for INMD and GMED.


Loading charts...

Drawdown Indicators


INMDGMEDDifference

Max Drawdown

Largest peak-to-trough decline

-86.96%

-47.91%

-39.05%

Max Drawdown (1Y)

Largest decline over 1 year

-23.23%

-22.10%

-1.13%

Max Drawdown (3Y)

Largest decline over 3 years

-70.44%

-44.40%

-26.04%

Max Drawdown (5Y)

Largest decline over 5 years

-86.96%

-47.91%

-39.05%

Max Drawdown (10Y)

Largest decline over 10 years

-47.91%

Current Drawdown

Current decline from peak

-84.53%

-18.62%

-65.91%

Average Drawdown

Average peak-to-trough decline

-56.60%

-15.35%

-41.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.91%

10.13%

+1.78%

Volatility

INMD vs. GMED - Volatility Comparison

The current volatility for InMode Ltd. (INMD) is 6.68%, while Globus Medical, Inc. (GMED) has a volatility of 12.47%. This indicates that INMD experiences smaller price fluctuations and is considered to be less risky than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INMDGMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.68%

12.47%

-5.79%

Volatility (6M)

Calculated over the trailing 6-month period

22.99%

26.28%

-3.29%

Volatility (1Y)

Calculated over the trailing 1-year period

33.43%

49.44%

-16.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.91%

38.45%

+13.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.45%

35.41%

+25.04%

Dividends

INMD vs. GMED - Dividend Comparison

Neither INMD nor GMED has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INMD vs. GMED - Financials Comparison

This section allows you to compare key financial metrics between InMode Ltd. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

INMD vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between InMode Ltd. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

INMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, InMode Ltd. reported a gross profit of 61.55M and revenue of 82.02M. Therefore, the gross margin over that period was 75.1%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.

INMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, InMode Ltd. reported an operating income of 10.06M and revenue of 82.02M, resulting in an operating margin of 12.3%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.

INMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, InMode Ltd. reported a net income of 11.56M and revenue of 82.02M, resulting in a net margin of 14.1%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.


Frequently Asked Questions


INMD and GMED have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GMED has higher volatility (12.47%) compared to INMD (6.68%). In terms of maximum drawdown, INMD dropped -86.96% vs GMED's -47.91%.

GMED currently has the higher Sharpe Ratio (1.01 vs 0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INMD and GMED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer